Cargando…
Diethylstilbestrol, a Novel ANO1 Inhibitor, Exerts an Anticancer Effect on Non-Small Cell Lung Cancer via Inhibition of ANO1
Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer-related mortality; thus, therapeutic targets continue to be developed. Anoctamin1 (ANO1), a novel drug target considered for the treatment of NSCLC, is a Ca(2+)-activated chloride channel (CaCC) overexpressed in various carcin...
Autores principales: | Seo, Yohan, Jeong, Sung Baek, Woo, Joo Han, Kwon, Oh-Bin, Lee, Sion, Oh, Hye In, Jo, Sungwoo, Park, Seon Ju, Namkung, Wan, Moon, Uk Yeol, Lee, Sungwoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269135/ https://www.ncbi.nlm.nih.gov/pubmed/34281152 http://dx.doi.org/10.3390/ijms22137100 |
Ejemplares similares
-
Cinobufagin Exerts Anticancer Activity in Oral Squamous Cell Carcinoma Cells through Downregulation of ANO1
por: Jo, Sungwoo, et al.
Publicado: (2021) -
Novel ANO1 Inhibitor from Mallotus apelta Extract Exerts Anticancer Activity through Downregulation of ANO1
por: Seo, Yohan, et al.
Publicado: (2020) -
Ani9, A Novel Potent Small-Molecule ANO1 Inhibitor with Negligible Effect on ANO2
por: Seo, Yohan, et al.
Publicado: (2016) -
Inhibition of ANO1 by luteolin and its cytotoxicity in human prostate cancer PC-3 cells
por: Seo, Yohan, et al.
Publicado: (2017) -
ANO1-downregulation induced by schisandrathera D: a novel therapeutic target for the treatment of prostate and oral cancers
por: Park, SeonJu, et al.
Publicado: (2023)